New blood test could detect cognitive decline early

Credit: Unsplash+

Extreme stressors such as childhood neglect, abuse, and psychiatric disorders can lead to various health problems later in life, including depression, anxiety, and cardiovascular disease.

A new study conducted by researchers in the Penn State Center for Healthy Aging has identified genetic indicators that can predict cognitive decline among individuals who have experienced these extreme stressors.

The study aims to understand the connection between accelerated biological aging, often observed in those affected by stressors, and cognitive decline, offering insights into potential treatments and prevention strategies.

Accelerated Biological Aging and Cognitive Decline

Extreme stressors can lead to accelerated biological aging, causing cells to age faster and the body to deteriorate at an earlier age. Cognitive functions, such as memory, reasoning, executive function, and processing speed, naturally decline with age.

Previous research has produced mixed results regarding whether accelerated biological aging accelerates cognitive decline. This study aims to clarify this relationship.

Research Findings

The researchers evaluated two separate population samples and found evidence that accelerated biological aging may serve as a biomarker for cognitive decline.

They used blood samples and medical data from the Female Growth and Development Study (FGDS) and the Biological Classification of Mental Disorders (BeCOME) to examine potential genetic indicators of cognitive performance. Key findings include:

Accelerated Aging Predicts Cognitive Decline: The study suggests that accelerated biological aging can predict lower cognitive ability and slower processing speed.

Different Genetic Indicators: The specific genetic indicators associated with this relationship differed between the FGDS and BeCOME cohorts. This discrepancy may be due to differences in study design, age range, and other factors.

Early Identification and Treatment: Early cognitive decline is detectable for decades before it significantly affects quality of life. This creates an opportunity for early identification and treatment.

Implications for Personalized Treatment

Understanding the connection between accelerated biological aging and cognitive decline can lead to the development of blood tests for early identification of cognitive decline.

Personalized treatments to support cognitive function in individuals with accelerated biological aging may also become possible.

This research has significant implications for improving the health and well-being of individuals affected by extreme stressors.

Identifying genetic indicators related to cognitive decline in individuals exposed to extreme stressors is a critical step in addressing the long-term health consequences of such experiences.

By understanding the genetic underpinnings of cognitive decline, researchers can work towards early identification, treatment, and prevention strategies to support cognitive function and overall well-being in affected individuals.

If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.

For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.

The research findings can be found in the Neurobiology of Stress.

Copyright © 2023 Knowridge Science Report. All rights reserved.